Intravascular infusions of soluble β-amyloid compromise the blood- brain barrier, activate CNS glial cells and induce peripheral hemorrhage

Brain Research

Volumn 818, Issue 1, 1999, Pages 105-117

  Su, George C ^a   Arendash, Gary W ^a   Kalaria, Rajesh N ^b   Bjugstad, Kimberly B ^a   Mullan, Michael ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

amyloid; Alzheimer's disease; Astrocytes; Blood brain barrier; Hemorrhage; Microglia

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BLOOD BRAIN BARRIER; BLOOD VESSEL WALL; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; GLIA CELL; INTRAVENOUS DRUG ADMINISTRATION; LUNG HEMORRHAGE; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

AMYLOID BETA-PROTEIN; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CEREBRAL HEMORRHAGE; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; INFUSIONS, INTRAVENOUS; MALE; MAZE LEARNING; NEUROGLIA; RATS; RATS, SPRAGUE-DAWLEY; RETENTION (PSYCHOLOGY); SOLUBILITY;

EID: 0033528254     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01143-3     Document Type: Article

References (63)

1. Abraham C.R., Selkoe D.J., Potter H. Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell. 52:1988;487-501.
2. Anda T., Yamashita H., Khalid H., Tsutsumi K., Fujita H., Tokunaga Y., Shibata S. Effect of tumor necrosis factor-alpha on the permeability of bovine brain microvessel endothelial cell monolayers. Neurol. Res. 19:1997;369-376.
3. Araujo D.M., Cotman C.W. β-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res. 569:1992;141-145.
4. Ard M.D., Cole G.M., Wei J., Mehrle A.P., Fratkin J.D. Scavenging of Alzheimer's amyloid β-protein by microglia in culture. J. Neurosci. Res. 43:1996;190-202.
5. Arispe N., Pollard H.B., Rojas E. Giant multilevel cation channels formed by Alzheimer disease amyloid β-protein [AβP-(1-40)] in bilayer membranes. Proc. Natl. Acad. Sci. USA. 90:1993;10573-10577.
6. Barger S.W., Harmon A.D. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature. 388:1997;878-881.
7. Beach T.G., Walker R., McGeer E.G. Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia. 2:1989;420-436.
8. K.B. Bjugstad, G.W. Arendash, An intracerebral TNF-α infusion model for inflammation in Alzheimer's disease, In: D.F. Emerich, R.L. Dean III, P.R. Sandberg (Eds.), Innovative Animal Models of CNS Diseases: From Molecule to Therapy, Humana Press, Totowa, in press.
9. Blanc E.M., Toborek M., Mark R.J., Hennig B., Mattson M.P. Amyloid β-peptide induces cell monlayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J. Neurochem. 68:1997;1870-1881.
10. Buee L., Hof P.R., Bouras C., Delacourte A., Perl D.P., Morrison J.H., Fillit H.M. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol. 87:1994;469-480.
11. Buee L., Hof P.R., Delacourte A. Brain microvascular changes in Alzheimer's disease and other dementias. Ann. N.Y. Acad. Sci. 826:1997;7-24.
12. Chen M., Inestrosa C.N., Ross G.S., Fernandez H.L. Platelets are the primary source of amyloid β-peptide in human blood. Biochem. Biophys. Res. Commun. 213:1995;96-103.
13. Ciallella J.R., Rangnekar V.V., McGillis J.P. Heat shock alters Alzheimer's β amyloid precursor protein expression in human endothelial cells. J. Neurosci. Res. 36:1994;776-796.
14. Cullen K.M. Perivascular astrocytes within Alzheimer's disease plaques. NeuroReport. 8:1997;1961-1966.
15. Davis-Salinas J., Saporito-Irwin S.M., Cotman C.W., Van Nostrand W.E. Amyloid β-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J. Neurochem. 65:1995;931-934.
16. J.C. de la Torre, V. Hachinski, (Eds.), Cerebrovascular Pathology in Alzheimer's Disease. Annals of the New York Academy of Sciences, Vol. 826, New York Academy of Sciences, New York, 1997, 523 pp.
17. Ellis R.J., Olichney J.M., Thal L.J., Mirra S.S., Morris J.C., Beekly D., Heyman A. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology. 46:1996;1592-1596.
18. Emre M., Geula C., Ransil B.J., Mesulam M.M. The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected β-amyloid in the rat brain. Neurobiol. Aging. 13:1992;553-559.
19. Engstrom I., Ronquist G., Pettersson L., Waldenstrom A. Alzheimer amyloid β-peptides exhibit ionophore-like properties in human erythrocytes. Eur. J. Clin. Invest. 25:1995;471-476.
20. Fels A.O., Cohn Z.A. The alveolar macrophage. J. Appl. Physiol. 60:1986;353-369.
21. Fiala M., Looney D.J., Stins M., way D.D., Zhang L., Gan X., Chiappelli F., Schweitzer E.S., Shapshak P., Weinand M., Graves M.C., Witte M., Kim K.S. TNF-α opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Mol. Med. 3:1997;553-564.
22. Fischer B., Shmoll H., Riederer P., Bauer J., Platt D., Popa-Wagner A. Complement C1q and C3 mRNA expression in the frontal cortex of Alzheimer's patients. J. Mol. Med. 73:1995;465-471.
23. Fukuchi K., Ho L., Younkin S.G., Kunkel D.D., Ogburn C.E., LeBoeuf R.C., Furlong C.E., Deeb S.S., Nochlin D., Wegiel J., Wisniewski H.M., Martin G.M. High levels of circulating β-amyloid peptide do not cause cerebral β-amyloidosis in transgenic mice. Am. J. Pathol. 149:1996;219-227.
24. Funato H., Yoshimura M., Yamazaki T., Saido T.C., Ito Y., Yokofujita J., Okeda R., Ihara Y. Astrocytes containing amyloid β-protein (Aβ)-positive granules are associated with Aβ40-positive diffuse plaques in the aged human brain. Am. J. Pathol. 152:1998;983-992.
25. Gloor S.M., Weber A., Adachi N., Frei K. Interleukin-1 modulates protein tyrosine phosphatase activity and permeability of brain endothelial cells. Biochem. Biophys. Res. Commun. 239:1997;804-809.
26. Goodwin J.L., Uemura E., Cunnick J.E. Microglial release of nitric oxide by the synergistic action of β-amyloid and IFN-γ Brain Res. 692:1995;207-214.
27. Griffin W.S., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C.L. III, Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA. 86:1989;7611-7615.
28. Hamano T., Yoshimura M., Yamazaki T., Shinkai Y., Yanagisawa K., Kuriyama M., Ihara Y. Amyloid β-protein (Aβ) accumulation in the leptomeninges during aging and in Alzheimer disease. J. Neuropathol. Exp. Neurol. 56:1997;922-932.
29. Hull M., Fiebich B.L., Lieb K., Strauss S., Berger M., Volk B., Bauer J. Interleukin-6-associated inflammatory processes in Alzheimer's disease: new therapeutic options. Neurobiol. Aging. 17:1996;795-800.
30. Itagaki S., McGeer P.L., Akiyama H., Zhu S., Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 24:1989;173-182.
31. Joachim C.L., Duffy L.K., Morris J.H., Selkoe D.J. Protein chemical and immunocytochemical studies of meningovascular β-amyloid protein in Alzheimer's disease and normal aging. Brain Res. 474:1988;100-111.
32. Kalaria R.N., Grahovac I. Serum amyloid P immunoreactivity in hippocampal tangles, plaques and vessels: implications for leakage across the blood-brain barrier in Alzheimer's disease. Brain Res. 516:1990;349-353.
33. Kalaria R.N. The blood-brain barrier and cerebral microcirculation in Alzheimer disease. Cerebrovasc. Brain Metab.Rev. 4:1992;226-260.
34. Kalaria R.N., Golde T.E., Kroon S.N., Perry G. The serine protease inhibitor antithrombin III and its mRNA in the pathogenesis of Alzheimer's disease. Am. J. Pathol. 142:1993;886-893.
35. Kalaria R.N. Cerebral vessels in ageing and Alzheimer's disease. Pharmacol. Ther. 73:1996;1-22.
36. Kalaria R.N., Hedera P. Differential degeneration of the cerebral microvasculature in Alzheimer's disease. NeuroReport. 6:1995;477-480.
37. Kalman J., Juhasz A., Laird G., Dickens P., Jardanhazy T., Rimanoczy A., Boncz I., Parry-Jones W.L.I, Janka Z. Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease. Acta Neurol. Scand. 96:1997;236-240.
38. Kawai M., Kalaria R.N., Cras P., Siedlak S.L., Velasco M.E., Shelton E.R., Chan H.W., Greenberg B.D., Perry G. Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Res. 623:1993;142-146.
39. Klegeris A., Walker D.G., McGeer P.L. Activation of macrophages by Alzheimer β amyloid peptide. Biochem. Biophys. Res. Commun. 199:1994;984-991.
40. J.F.R. Konig, R.A. Klippel (Eds.), The Rat Brain. A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brainstem, Robert E. Krieger, Huntington, 1963, 162 pp.
41. Kowall N.W., Beal M.F., Busciglio J., Duffy L.K., Yankner B.A. An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc. Natl. Acad. Sci. USA. 88:1991;6247-7251.
42. Mandybur T.I. Cerebral amyloid angiopathy and astrocytic gliosis in Alzheimer's disease. Acta Neuropathol. 78:1989;329-331.
43. Maness L.M., Banks W.A., Podlisny M.B., Selkoe D.J., Kastin A.J. Passage of human amyloid β-protein 1-40 across the murine blood-brain barrier. Life Sci. 55:1994;1643-1650.
44. Martel C.L., Mackic J.B., McComb J.G., Ghiso J., Zlokovic B.V. Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid β in guinea pigs. Neurosci. Lett. 206:1996;157-160.
45. McGeer P.L., Akiyama H., Itagaki S., McGeer E.G. Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci. Lett. 107:1989;341-346.
46. Meda L., Cassatella M.A., Szendrel G.I., Otvos L. Jr., Baron P., Villalba M., Ferrari D., Rossi F. Activation of microglial cells by β-amyloid protein and interferon-γ Nature. 374:1995;647-650.
47. Merrill J.E., Murphy S.P. Inflammatory events at the blood brain barrier: regulation of adhesion molecules, cytokines and chemokines by reactive nitrogen and oxygen species. Brain Behav. Immun. 11:1997;245-263.
48. Pike C.J., Cummings B.J., Monzavi R., Cotman C.W. β-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience. 63:1994;517-531.
49. Prelli F., Castano E., Glenner G.G., Frangione B. Differences between vascular and plaque core amyloid in Alzheimer's disease. J. Neurochem. 51:1988;648-651.
50. Price J.M., Sutton E.T., Hellermann A., Thomas T. β-amyloid induces cerebrovascular endothelial dysfunction in the rat brain. Neurological Res. 19:1997;534-538.
51. Puchtler H., Sweat F., Levine M. On the binding of Congo red by amyloid. J. Histochem. Cytochem. 10:1962;355-364.
52. 1-40/vector complex Proc. Natl. Acad. Sci. USA. 92:1995;10227-10231.
53. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2:1996;864-870.
54. Shinkai Y., Yoshimura M., Ito Y., Odaka A., Suzuki N., Yanagisawa K., Ihara Y. Amyloid β-proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessles. Ann. Neurol. 38:1995;421-428.
55. Thomas T., Thomas G., McLendon C., Sutton T., Mullan M. β-amyloid-mediated vasoactivity and vascular endothelial damage. Nature. 380:1996;168-171.
56. Thomas T., McLendon C., Sutton E.T., Thomas G. Cerebrovascular endothelial dysfunction mediated by β-amyloid. NeuroReport. 8:1997;1387-1391.
57. Uchihara T., Akiyama H., Kondo H., Ikeda K. Activated microglial cells are colocalized with perivascular deposits of amyloid-β protein in Alzheimer's disease brain. Stroke. 28:1997;1948-1950.
58. Vinters H.V. Cerebral amyloid angiopathy. A critical review. Stroke. 18:1987;311-324.
59. Wisniewski H.M., Vorbrodt A.W., Wegiel J. Amyloid angiopathy and blood-brain barrier changes in Alzheimer's disease. Ann. N.Y. Acad. Sci. 826:1997;161-172.
60. Wisniewski H.M., Frackowiak J., Mazur-Kolecka B. In vitro production of β-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels. Neurosci. Lett. 183:1995;120-123.
61. Yan S.D., Zhu H., Fu J., Yan S.F., Roher A., Tourtellotte W.W., Rajavashisth T., Chen X., Godman G.C., Stern D., Schimidt A.M. Amyloid-β peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 94:1997;5296-5301.
62. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.
63. Zlokovic B.V., Ghiso J., Mackic J.B., McComb J.G., Weiss M.H., Frangione B. Blood-brain barrier transport of circulating Alzheimer's amyloid β Biochem. Biophys. Res. Commun. 197:1993;1034-1040.